Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

[1]  B. Zrenner,et al.  ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing—The Prospective, Randomized, Multicentre TropShock-Trial , 2015, PloS one.

[2]  Jeffrey L. Anderson.  Evolution of the ACC/AHA Clinical Practice Guidelines in Perspective: Guiding the Guidelines. , 2015, Journal of the American College of Cardiology.

[3]  J. Svendsen,et al.  Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial , 2015, European heart journal.

[4]  A. Auricchio,et al.  Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. , 2015, Heart rhythm.

[5]  J. Pogue,et al.  Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE) , 2015, The Lancet.

[6]  D. Corrado,et al.  Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study , 2015, Journal of Interventional Cardiac Electrophysiology.

[7]  Paul J. Wang,et al.  The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. , 2015, European heart journal.

[8]  D. Babuty,et al.  Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. , 2014, JACC. Heart failure.

[9]  Shu Zhang,et al.  Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  A. Moss,et al.  Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) , 2014, Circulation. Arrhythmia and electrophysiology.

[11]  Jeffrey L. Anderson,et al.  The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[12]  M. Gold,et al.  Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. , 2014, Heart rhythm.

[13]  Angel Arenal,et al.  Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population: Data From the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) Trial , 2014, Circulation.

[14]  D. Lacroix,et al.  Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial , 2014, Journal of cardiovascular electrophysiology.

[15]  B. Wilkoff,et al.  The Epidemic of Inadequate Biventricular Pacing in Patients With Persistent or Permanent Atrial Fibrillation and Its Association With Mortality , 2014, Circulation. Arrhythmia and electrophysiology.

[16]  R. Quaglione,et al.  Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. , 2014, Heart rhythm.

[17]  S. Rosenheck,et al.  Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry. , 2014, Heart rhythm.

[18]  G. Boriani,et al.  Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial , 2014, European heart journal.

[19]  Á. Cequier,et al.  The Benefit of a Second Burst Antitachycardia Sequence for Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators , 2014, Pacing and clinical electrophysiology : PACE.

[20]  A. Russo,et al.  OUTCOME FOLLOWING ICD IMPLANTATION WITH VERSUS WITHOUT DEFIBRILLATION TESTING: PRELIMINARY RESULTS OF THE PROSPECTIVE RANDOMIZED TEST-NO TEST (TNT) PILOT STUDY , 2014 .

[21]  J. Healey,et al.  Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Should Not Be Routinely Performed at the Time of Implantable Cardioverter Defibrillator Implantation , 2014, Circulation. Arrhythmia and electrophysiology.

[22]  Xu Wang,et al.  Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis , 2014, Journal of Interventional Cardiac Electrophysiology.

[23]  A. Maruotti,et al.  Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut‐off criteria , 2014, European journal of heart failure.

[24]  D. Exner,et al.  Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[25]  S. Solomon,et al.  Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT. , 2014, European heart journal.

[26]  Y. Nabutovsky,et al.  Programming Implantable Cardioverter‐Defibrillators in Patients with Primary Prevention Indication to Prolong Time to First Shock: Results from the PROVIDE Study , 2014, Journal of cardiovascular electrophysiology.

[27]  K. Ellenbogen,et al.  Performance of Lead Integrity Alert to Assist in the Clinical Diagnosis of Implantable Cardioverter Defibrillator Lead Failures: Analysis of Different Implantable Cardioverter Defibrillator Leads , 2013, Circulation. Arrhythmia and electrophysiology.

[28]  J. Curtis,et al.  Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR® , 2013, Pacing and clinical electrophysiology : PACE.

[29]  K. Ellenbogen,et al.  Implantable cardioverter-defibrillator leads: design, diagnostics, and management. , 2013, Circulation.

[30]  P. Heidenreich,et al.  Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. , 2013, Journal of the American College of Cardiology.

[31]  P. Sanders,et al.  Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators. , 2013, The American journal of cardiology.

[32]  Mark Kremers,et al.  Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.

[33]  M. A. Arias,et al.  The reverse mode switch algorithm: how well does it work? , 2013, Heart rhythm.

[34]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[35]  T. Pereira,et al.  Inappropriate Shocks in Patients with ICDs: Single Chamber versus Dual Chamber , 2013, Arquivos brasileiros de cardiologia.

[36]  Mitchell W Krucoff,et al.  The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[37]  A. Proclemer,et al.  Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. , 2013, JAMA.

[38]  K. Smits,et al.  Impact of defibrillation testing on predicted ICD shock efficacy: implications for clinical practice. , 2013, Heart rhythm.

[39]  C. Sticherling,et al.  Role of Defibrillation Threshold Testing in the Contemporary Defibrillator Patient Population , 2013, Journal of cardiovascular electrophysiology.

[40]  R. Verheggen,et al.  Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients , 2013, Netherlands Heart Journal.

[41]  John Rumsfeld,et al.  The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. , 2013, Heart rhythm.

[42]  E. Kanal,et al.  ACR guidance document on MR safe practices: 2013 , 2013, Journal of magnetic resonance imaging : JMRI.

[43]  Dominique Lacroix,et al.  A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial , 2012, European heart journal.

[44]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[45]  J. Healey,et al.  A Randomized‐Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial , 2012, Journal of cardiovascular electrophysiology.

[46]  M. Stiles,et al.  Recommendations for the programming of implantable cardioverter-defibrillators in New Zealand. , 2012, Heart, lung & circulation.

[47]  David O. Martin,et al.  Atrial Support Pacing in Heart Failure: Results from the Multicenter PEGASUS CRT Trial , 2012, Journal of cardiovascular electrophysiology.

[48]  John Gorcsan,et al.  Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. , 2012, Heart rhythm.

[49]  S. González-Enríquez,et al.  Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better? , 2012, Journal of Interventional Cardiac Electrophysiology.

[50]  J. Sellal,et al.  Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[51]  H. Morita,et al.  Cardiac Dysfunction and Prolonged Hemodynamic Deterioration After Implantable Cardioverter-Defibrillator Shock in Patients With Systolic Heart Failure , 2012, Circulation. Arrhythmia and electrophysiology.

[52]  M. Brignole,et al.  Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. , 2012, Journal of the American College of Cardiology.

[53]  K. Bailey,et al.  Prospective Randomized Trial of Dual Chamber vs. Single Chamber ICDs to Minimize Shocks in Optimally Programmed Devices , 2012 .

[54]  Luigi Padeletti,et al.  A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[55]  A. Russo,et al.  HRS/ACCF expert consensus statement on pacemaker device and mode selection. , 2012, Journal of the American College of Cardiology.

[56]  S. Asirvatham,et al.  Noise, Artifact, and Oversensing Related Inappropriate ICD Shock Evaluation: ALTITUDE NOISE Study , 2012, Pacing and clinical electrophysiology : PACE.

[57]  L. Fauchier,et al.  Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[58]  W. Toff,et al.  Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[59]  J. Rey,et al.  Effect of a Pacing Mode Preserving Spontaneous AV Conduction on Ventricular Pacing Burden and Atrial Arrhythmias , 2012, Pacing and clinical electrophysiology : PACE.

[60]  C. Swerdlow,et al.  A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm. , 2012, Heart rhythm.

[61]  M. Gold,et al.  Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.

[62]  A. Russo,et al.  Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial. , 2012, Heart rhythm.

[63]  A. Ducharme,et al.  Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds , 2011, Circulation.

[64]  M. Link,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[65]  K. Ellenbogen,et al.  Advances in Arrhythmia and Electrophysiology Minimizing Inappropriate or “Unnecessary” Implantable Cardioverter-Defibrillator Shocks Appropriate Programming , 2011 .

[66]  N. Uriel,et al.  Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[67]  Emily A. Kuhl,et al.  The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. , 2011, Journal of psychosomatic research.

[68]  A. Dhala,et al.  Inappropriate Shocks in Patients With Fidelis® Lead Fractures: Impact of Remote Monitoring and the Lead Integrity Algorithm , 2011, Journal of cardiovascular electrophysiology.

[69]  P. Friedman,et al.  Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators , 2011 .

[70]  P. Heidenreich,et al.  Real World Evaluation of Dual‐Zone ICD and CRT‐D Programming Compared to Single‐Zone Programming: The ALTITUDE REDUCES Study , 2011, Journal of cardiovascular electrophysiology.

[71]  P. Heidenreich,et al.  Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. , 2011, Heart rhythm.

[72]  M. Fleckenstein,et al.  Reduction of Right Ventricular Pacing with Advanced Atrioventricular Search Hysteresis: Results of the PREVENT Study , 2011, Pacing and clinical electrophysiology : PACE.

[73]  G. Lloyd,et al.  The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[74]  J. Conti,et al.  Posttraumatic Stress and the Implantable Cardioverter-Defibrillator Patient: What the Electrophysiologist Needs to Know , 2011, Circulation. Arrhythmia and electrophysiology.

[75]  P. Khairy,et al.  Programming ICDs in the Modern Era beyond Out‐of‐the Box Settings , 2011, Pacing and clinical electrophysiology : PACE.

[76]  D. Exner,et al.  Combining Shock Reduction Strategies to Enhance ICD Therapy: A Role for Computer Modeling , 2011, Journal of cardiovascular electrophysiology.

[77]  W. Toff,et al.  A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. , 2011, European heart journal.

[78]  M. Chauvin,et al.  Outcome of patients aged over 75 years who received a pacemaker to treat sinus node dysfunction. , 2011, Archives of cardiovascular diseases.

[79]  Suneet Mittal,et al.  Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchron , 2010, Circulation.

[80]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[81]  J. Healey,et al.  Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry , 2010, Journal of cardiovascular electrophysiology.

[82]  A. Massumi,et al.  Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial , 2010, Journal of cardiovascular electrophysiology.

[83]  K. Ellenbogen,et al.  Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.

[84]  K. Ellenbogen,et al.  Downloadable Software Algorithm Reduces Inappropriate Shocks Caused by Implantable Cardioverter-Defibrillator Lead Fractures: A Prospective Study , 2010, Circulation.

[85]  M. Santini,et al.  BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. , 2010, American heart journal.

[86]  Manish S. Gupta,et al.  Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. , 2010, American heart journal.

[87]  B. Wilkoff,et al.  Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.

[88]  J. Healey,et al.  Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing , 2010, Journal of cardiovascular electrophysiology.

[89]  M. Santini,et al.  Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results , 2010, Journal of Interventional Cardiac Electrophysiology.

[90]  Paul A. Belk,et al.  The Relationship between Pacing Site and Induction or Termination of Sustained Monomorphic Ventricular Tachycardia by Antitachycardia Pacing , 2010, Pacing and clinical electrophysiology : PACE.

[91]  D. Slotwiner,et al.  Frequent Recurrent Polymorphic Ventricular Tachycardia during Sleep Due to Managed Ventricular Pacing , 2009, Pacing and clinical electrophysiology : PACE.

[92]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[93]  T. Murohara,et al.  Difference in percentage of ventricular pacing between two algorithms for minimizing ventricular pacing: results of the IDEAL RVP (Identify the Best Algorithm for Reducing Unnecessary Right Ventricular Pacing) study , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[94]  Jesús Requena-Carrión,et al.  Sensitivity and Spatial Resolution of Transvenous Leads in Implantable Cardioverter Defibrillator , 2009, IEEE Transactions on Biomedical Engineering.

[95]  Jeroen J. Bax,et al.  Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. , 2009, Journal of the American College of Cardiology.

[96]  P. Pascale,et al.  Pacemaker Syndrome During Managed Ventricular Pacing Mode: What is the Mechanism? , 2009, Journal of cardiovascular electrophysiology.

[97]  B. Zrenner,et al.  Defibrillation Threshold Testing: Tradition or Necessity? , 2009, Pacing and clinical electrophysiology : PACE.

[98]  M. Scherillo,et al.  A Randomized Study to Compare Ramp Versus Burst Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: The PITAGORA ICD Trial , 2009, Circulation. Arrhythmia and electrophysiology.

[99]  P. Kudenchuk,et al.  The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. , 2009, Journal of the American College of Cardiology.

[100]  Wilfried Mullens,et al.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. , 2009, Journal of the American College of Cardiology.

[101]  Alfons F. Sinnaeve,et al.  Sensing and Detection , 2009 .

[102]  S. A. Christman,et al.  Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? , 2009, Journal of the American College of Cardiology.

[103]  K. Ellenbogen,et al.  Downloadable Algorithm to Reduce Inappropriate Shocks Caused by Fractures of Implantable Cardioverter-Defibrillator Leads , 2008, Circulation.

[104]  Paul A. Belk,et al.  Severe Atrioventricular Decoupling, Uncoupling, and Ventriculoatrial Coupling During Enhanced Atrial Pacing: Incidence, Mechanisms, and Implications for Minimizing Right Ventricular Pacing in ICD Patients , 2008, Journal of cardiovascular electrophysiology.

[105]  A. Thiagalingam,et al.  Discriminatory Therapy for Very Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators , 2008, Pacing and clinical electrophysiology : PACE.

[106]  C. Işıkay,et al.  Defibrillation testing and early neurologic outcome. , 2008, International heart journal.

[107]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[108]  D. Mark,et al.  No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). , 2008, Journal of the American College of Cardiology.

[109]  S. Sears,et al.  State‐of‐the‐art: anxiety management in patients with implantable cardioverter defibrillators , 2008 .

[110]  C. Wolpert,et al.  Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[111]  Wojciech Zareba,et al.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.

[112]  J. Healey,et al.  Complications associated with defibrillation threshold testing: the Canadian experience. , 2008, Heart rhythm.

[113]  C. Israel,et al.  Comparison of Two Strategies to Reduce Ventricular Pacing in Pacemaker Patients , 2008, Pacing and clinical electrophysiology : PACE.

[114]  M. Mollerus,et al.  Myocardial stunning following defibrillation threshold testing , 2007, Journal of Interventional Cardiac Electrophysiology.

[115]  G. Lamas,et al.  Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. , 2007, The New England journal of medicine.

[116]  G. Lamas,et al.  Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). , 2007, Heart rhythm.

[117]  Paul A. Belk,et al.  Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? , 2007, Journal of the American College of Cardiology.

[118]  G. O'hara,et al.  Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging. , 2007, Heart rhythm.

[119]  A. Russo,et al.  The Dilemma of ICD Implant Testing , 2007, Pacing and clinical electrophysiology : PACE.

[120]  J. Day,et al.  Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator?: Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study , 2006, Circulation.

[121]  Arjun D. Sharma,et al.  Improving SVT Discrimination in Single‐Chamber ICDs: A New Electrogram Morphology‐Based Algorithm , 2006, Journal of cardiovascular electrophysiology.

[122]  I. V. Van Gelder,et al.  Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. , 2006, Heart rhythm.

[123]  A. Skanes,et al.  Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. , 2006, American heart journal.

[124]  Dick M. Goedhart,et al.  Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators. , 2006, Heart rhythm.

[125]  Zengri J. Wang,et al.  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. , 2006, Journal of the American College of Cardiology.

[126]  L. Goldman,et al.  Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data , 2006, Circulation.

[127]  C. Israel,et al.  Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block , 2006, Pacing and clinical electrophysiology : PACE.

[128]  W. Bamlet,et al.  Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study , 2006, Circulation.

[129]  K. Ellenbogen,et al.  Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. , 2006, Heart rhythm.

[130]  L. Di Biase,et al.  Is a Dual‐Sensor Pacemaker Appropriate in Patients with Sino‐Atrial Disease? Results from the DUSISLOG Study , 2006, Pacing and clinical electrophysiology : PACE.

[131]  M. Pitt,et al.  The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. , 2005, Health technology assessment.

[132]  Arjun D. Sharma,et al.  Percent right ventricular pacing predicts outcomes in the DAVID trial. , 2005, Heart rhythm.

[133]  A. Camm,et al.  Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. , 2005, The New England journal of medicine.

[134]  B. Wilkoff,et al.  Optimal Combination of Discriminators for Differentiating Ventricular from Supraventricular Tachycardia by Dual‐Chamber Defibrillators , 2005, Journal of cardiovascular electrophysiology.

[135]  M. Sweeney,et al.  Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial , 2005, Circulation.

[136]  A. Russo,et al.  Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? , 2005, Heart rhythm.

[137]  Paul J. Wang,et al.  The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II , 2005, Journal of cardiovascular electrophysiology.

[138]  S. Vonhof,et al.  Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. , 2005, Heart rhythm.

[139]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[140]  Dick M. Goedhart,et al.  Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. , 2004, Journal of the American College of Cardiology.

[141]  S. Kimber,et al.  Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. , 2004, Heart rhythm.

[142]  Michael O. Sweeney,et al.  Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.

[143]  S. Hohnloser,et al.  The 1+1 Trial: A Prospective Trial of a Dual- Versus a Single-Chamber Implantable Defibrillator in Patients With Slow Ventricular Tachycardias , 2004, Circulation.

[144]  Simonetta Dell'Orto,et al.  Sensors for rate responsive pacing , 2004, Indian pacing and electrophysiology journal.

[145]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[146]  J. Kron.  Clinical significance of device-related complications in clinical trials and implications for future trials: insights from the Antiarrhytmics Versus Implantable Defibrillators (AVID) trial. , 2003, Cardiac electrophysiology review.

[147]  D. Wyse,et al.  Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2003, Journal of cardiovascular electrophysiology.

[148]  G. Lamas,et al.  Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.

[149]  K. Nanthakumar,et al.  Is Inappropriate Implantable Defibrillator Shock Therapy Predictable? , 2003, Journal of Interventional Cardiac Electrophysiology.

[150]  R. Stadler,et al.  An Adaptive Interval‐Based Algorithm for Withholding ICD Therapy During Sinus Tachycardia , 2003, Pacing and clinical electrophysiology : PACE.

[151]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[152]  M. Jensen-Urstad,et al.  Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management. , 2002, The American journal of medicine.

[153]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[154]  M. Sweeney.  Novel Cause of Spurious Mode Switching in Dual‐Chamber Pacemakers: Atrioventricular Desynchronization Arrhythmia , 2002, Journal of cardiovascular electrophysiology.

[155]  Walter H Olson,et al.  Discrimination of Ventricular Tachycardia from Supraventricular Tachycardia by a Downloaded Wavelet‐Transform Morphology Algorithm: A Paradigm for Development of Implantable Cardioverter Defibrillator Detection Algorithms , 2002, Journal of cardiovascular electrophysiology.

[156]  M. Gold,et al.  Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS) , 2002, Circulation.

[157]  C. Visser,et al.  The Effect of Rate Responsive Pacing in Patients with Angina Pectoris on the Extent of Ischemia on 201‐Thallium Exercise Scintigraphy , 2002, Pacing and clinical electrophysiology : PACE.

[158]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[159]  Judy Powell,et al.  Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks , 2002, Circulation.

[160]  R. Lazzara,et al.  Analysis of Troponin I Levels After Spontaneous Implantable Cardioverter Defibrillator Shocks , 2002, Journal of cardiovascular electrophysiology.

[161]  G. Breithardt,et al.  Effect of Ventricular Fibrillation Duration on the Defibrillation Threshold in Humans , 2002, Pacing and clinical electrophysiology : PACE.

[162]  Michael O. Sweeney,et al.  Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease , 2001, Circulation.

[163]  C. Swerdlow.  Implantation of Cardioverter Defibrillators Without Induction of Ventricular Fibrillation , 2001, Circulation.

[164]  H. Baum,et al.  Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. , 2001, Clinical chemistry.

[165]  K. Ellenbogen,et al.  Critical Analysis of Dual-Chamber Implantable Cardioverter-Defibrillator Arrhythmia Detection: Results and Technical Considerations , 2001, Circulation.

[166]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[167]  M Gent,et al.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .

[168]  C. Lau,et al.  Developments in sensor-driven pacing. , 2000, Cardiology clinics.

[169]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[170]  B. Waldecker,et al.  Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. , 1999, Journal of the American College of Cardiology.

[171]  A. Camm,et al.  Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review , 1999, Clinical cardiology.

[172]  G. Breithardt,et al.  Efficacy and Safety of the Initial Use of Stability and Onset Criteria in Implantable Cardioverter Defibrillators , 1999, Journal of cardiovascular electrophysiology.

[173]  Wojciech Zareba,et al.  Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol , 1999 .

[174]  M. Rosenqvist,et al.  Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. , 1998, Circulation.

[175]  J. Diephuis,et al.  Changes in Cerebral Oxygen Uptake and Cerebral Electrical Activity During Defibrillation Threshold Testing , 1998, Anesthesia and analgesia.

[176]  L. Goldman,et al.  Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. , 1998, Pacing and clinical electrophysiology : PACE.

[177]  J. Brugada,et al.  Enhanced Detection Criteria in Implantable Defibrillators , 1998, Journal of cardiovascular electrophysiology.

[178]  J. Brugada,et al.  Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction , 1997, Pacing and clinical electrophysiology : PACE.

[179]  R. Peters,et al.  Complications Associated with Pectoral Implantation of Cardioverter Defibrillators , 1997, Pacing and clinical electrophysiology : PACE.

[180]  M. Gold,et al.  Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. , 1996, The American journal of cardiology.

[181]  R. Yee,et al.  Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. , 1996, Journal of the American College of Cardiology.

[182]  G. Wieneke,et al.  The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation. , 1996, Electroencephalography and clinical neurophysiology.

[183]  A. Tajik,et al.  Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study. , 1996, Journal of the American College of Cardiology.

[184]  S. Pinski,et al.  The proarrhythmic potential of implantable cardioverter-defibrillators. , 1995, Circulation.

[185]  M. Schlepper,et al.  Programmable VT Detection Enhancements in Implantable Cardioverter Defibrillator Therapy , 1995, Pacing and clinical electrophysiology : PACE.

[186]  E. Gang,et al.  Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. , 1994, Journal of the American College of Cardiology.

[187]  A. Natale,et al.  Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: comparison with a standard monophasic device using the same lead system. , 1994, Journal of the American College of Cardiology.

[188]  P. S. Chen,et al.  Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. , 1994, Journal of the American College of Cardiology.

[189]  H. Edmonds,et al.  Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing. , 1994, American heart journal.

[190]  M. Schlepper,et al.  Effect of Biphasic Waveform Pulse on Endocardial Defibrillation Efficacy in Humans , 1994, Pacing and clinical electrophysiology : PACE.

[191]  B. Lüderitz,et al.  Patient Acceptance of the Implantable Cardioverter Defibrillator in Ventricular Tachyarrhythmias , 1993, Pacing and clinical electrophysiology : PACE.

[192]  F. Marchlinski,et al.  Shock Occurrence and Survival in 241 Patients With Implantable Cardioverter‐ Defibrillator Therapy , 1993, Circulation.

[193]  J. Fisher,et al.  Initial Experience with Transvenous Implantable Cardioverter Defibrillator Lead Systems: Operative Morbidity and Mortality , 1993, Pacing and clinical electrophysiology : PACE.

[194]  F. Marchlinski,et al.  Electrocardiographically Documented Unnecessary, Spontaneous Shocks in 241 Patients With Implantable Cardioverter Defibrillators , 1992, Pacing and clinical electrophysiology : PACE.

[195]  K. Ellenbogen,et al.  Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. , 1992, The American journal of cardiology.

[196]  J. Fisher,et al.  Clinical Evaluation of the Safety of Repetitive Intraoperative Defibrillation Threshold Testing , 1992, Pacing and clinical electrophysiology : PACE.

[197]  H. Müderrisoğlu,et al.  Quality of Life in Patients with Rate Responsive Pacemakers: A Randomized, Cross‐Over Study , 1991, Pacing and clinical electrophysiology : PACE.

[198]  N Sulke,et al.  A randomized double-blind crossover comparison of four rate-responsive pacing modes. , 1991, Journal of the American College of Cardiology.

[199]  A. Camm,et al.  Symptomatology and quality of life in patients with rate‐responsive pacemakers: A double‐blind, randomized, crossover study , 1989, Clinical cardiology.

[200]  P. Brugada,et al.  Pacemaker Syndrome with AAI Rate Variable Pacing: Importance of Atrioventricular Conduction Properties, Medication, and Pacemaker Programmability , 1988, Pacing and clinical electrophysiology : PACE.

[201]  V L Gott,et al.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.

[202]  B. Lown,et al.  Implanted Standby Defibrillators , 1972, Circulation.

[203]  A. Proclemer,et al.  Efficacy of Long Detection Interval ICD Settings in Secondary Prevention Population: Data from the Advance III Trial , 2014 .

[204]  J. Makaryus,et al.  Inappropriate Implant­ able Cardioverter­ Defibrillator Shocks , 2014 .

[205]  A. Meta-analysis,et al.  The Impact of Prolonged ICD Arrhythmia Detection , 2014 .

[206]  B. Wilkoff,et al.  The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. , 2012, Heart rhythm.

[207]  L. S. Mathias,et al.  Impact of induced cardiac arrest on cognitive function after implantation of a cardioverter-defibrillator. , 2009, Revista brasileira de anestesiologia.

[208]  A. Waldo.  Four-Year Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression: The Importance of Performing Atrioventricular Junction Ablation in Patients With Atrial FibrillationGasparini M, Auricchio A, Regoli F, et al (IRCCS Instituto, Milan, Italy; IRCCS Policlinico San M , 2007 .

[209]  P. Friedman,et al.  Advanced ICD troubleshooting: Part I. , 2005, Pacing and clinical electrophysiology : PACE.

[210]  J. W. Atkinson,et al.  Cardiac arrhythmias. , 2005, Respiratory care clinics of North America.

[211]  Alain Ripart,et al.  Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[212]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.